The point-of-care laboratory in clinical microbiology

Clinical Microbiology Reviews

Volumn 29, Issue 3, 2016, Pages 429-447

  Drancourt, Michel ^a   Michel Lepage, Audrey ^a,b   Boyer, Sylvie ^b   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; GASTROINTESTINAL INFECTION; GENITAL TRACT INFECTION; HEALTH CARE ORGANIZATION; IMMUNOAFFINITY CHROMATOGRAPHY; INFECTION; INFECTION CONTROL; LOWEST INCOME GROUP; MALARIA; MENINGITIS; MICROBIOLOGY TEST; MICROORGANISM DETECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PHARYNGITIS; PNEUMONIA; POINT OF CARE TESTING; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRAINING; TUBERCULOSIS; VAGINITIS; COMMUNICABLE DISEASES; COST BENEFIT ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIAGNOSTIC KIT; EARLY DIAGNOSIS; ECONOMICS; HUMAN; ORGANIZATION AND MANAGEMENT; POINT OF CARE SYSTEM;

DIAGNOSTIC KIT;

COMMUNICABLE DISEASES; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EARLY DIAGNOSIS; HUMANS; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC;

EID: 84962106981     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00090-15     Document Type: Article

References (118)

1. Fournier PE, Drancourt M, Colson P, Rolain JM, La Scola B, Raoult D. 2013. Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol 11:574-585. http://dx.doi.org/10.1038/nrmicro3068.
2. Bossuyt X, Verweire K, Blanckaert N. 2007. Laboratory medicine: challenges and opportunities. Clin Chem 53:1730-1733. http://dx.doi.org/10.1373/clinchem.2007.093989.
3. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297-301.
4. Sokhna C, Mediannikov O, Fenollar F, Bassene H, Diatta G, Tall A, Trape JF, Drancourt M, Raoult D. 2013. Point-of-care laboratory of pathogen diagnosis in rural Senegal. PLoS Negl Trop Dis 7:e1999. http: //dx.doi.org/10.1371/journal.pntd.0001999.
5. Bouricha M, Samad MA, Levy PY, Raoult D, Drancourt M. 2014. Point-of-care syndrome-based, rapid diagnosis of infections on commercial ships. J Travel Med 21:12-16. http://dx.doi.org/10.1111/jtm.12090.
6. Schito M, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW. 2012. Opportunities and challenges for cost-efficient implementation of new point-ofcare diagnostics for HIV and tuberculosis. J Infect Dis 205 (Suppl 2): S169-S180. http://dx.doi.org/10.1093/infdis/jis044.
7. Kost GJ. 2002. Principles and practice of point-of-care testing, 1st ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Price CP. 2001. Point of care testing. BMJ 322:1285-1288. http://dx.doi.org/10.1136/bmj.322.7297.1285.
9. Reid A. 2012. Bringing the lab to the patient: developing point-of-care diagnostics for resource limited settings. American Academy of Microbiology, Washington, DC.
10. Peeling RW, Mabey D. 2010. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 16:1062-1069. http://dx.doi.org/10.1111/j.1469-0691.2010.03279.x.
11. Ninove L, Gazin C, Gould EA, Nougairede A, Flahault A, Charrel RN, Zandotti C, de Lamballerie X. 2010. Impact of diagnostic procedures on patient management and hospitalization cost during the 2000 and 2005 enterovirus epidemics in Marseilles, France. Clin Microbiol Infect 16: 651-656. http://dx.doi.org/10.1111/j.1469-0691.2009.02915.x.
12. Rashid H, Shafi S, Haworth E, El Bashir H, Ali KA, Memish ZA, Booy R. 2007. Value of rapid testing for influenza among Hajj pilgrims. Travel Med Infect Dis 5:310-313. http://dx.doi.org/10.1016/j.tmaid.2007.07.006.
13. Nie S, Roth RB, Stiles J, Mikhlina A, Lu X, Tang YW, Babady NE. 2014. Evaluation of Alere i Influenza A and B for rapid detection of influenza viruses A and B. J Clin Microbiol 52:3339-3344. http://dx.doi.org/10.1128/JCM.01132-14.
14. Francois P, Tangomo M, Hibbs J, Bonetti EJ, Boehme CC, Notomi T, Perkins MD, Schrenzel J. 2011. Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications. FEMS Immunol Med Microbiol 62:41-48. http://dx.doi.org/10.1111/j.1574-695X.2011.00785.x.
15. Sattabongkot J, Tsuboi T, Han ET, Bantuchai S, Buates S. 2014. Loop-mediated isothermal amplification assay for rapid diagnosis of malaria infections in an area of endemicity in Thailand. J Clin Microbiol 52:1471-1477. http://dx.doi.org/10.1128/JCM.03313-13.
16. Beissner M, Phillips RO, Battke F, Bauer M, Badziklou K, Sarfo FS, Maman I, Rhomberg A, Piten E, Frimpong M, Huber KL, Symank D, Jansson M, Wiedemann FX, Banla Kere A, Herbinger KH, Löscher T, Bretzel G. 2015. Loop-mediated isothermal amplification for laboratory confirmation of Buruli ulcer disease—towards a pointof-care test. PLoS Negl Trop Dis 9:e0004219. http://dx.doi.org/10.1371/journal.pntd.0004219.
17. Drancourt M, Gaydos CA, Summersgill JT, Raoult D. 2013. Point-ofcare testing for community-acquired pneumonia. Lancet Infect Dis 13: 647-649. http://dx.doi.org/10.1016/S1473-3099(13)70165-8.
18. Tan JJ, Capozzoli M, Sato M, Watthanaworawit W, Ling CL, Mauduit M, Malleret B, Grüner AC, Tan R, Nosten FH, Snounou G, Rénia L, Ng LF. 2014. An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens. PLoS Negl Trop Dis 8:e3043. http://dx.doi.org/10.1371/journal.pntd.0003043.
19. Thamcharoen N, Sornprom S, Permpalung N, Hyman CL. 2015. False positivity of monospot test in an immunocompetent elderly woman with acute cytomegalovirus infection. Am J Emerg Med 33:1544.e1-1544.e2. http://dx.doi.org/10.1016/j.ajem.2015.07.028.
20. Cunha BA, Munoz-Gomez S. 2014. Dengue fever in a returning traveller from El Salvador: another cause of a false positive monospot test. Travel Med Infect Dis 12:293-295. http://dx.doi.org/10.1016/j.tmaid.2014.02.005.
21. Kesavan SV, Momey F, Cioni O, David-Watine B, Dubrulle N, Shorte S, Sulpice E, Freida D, Chalmond B, Dinten JM, Gidrol X, Allier C. 2014. High-throughput monitoring of major cell functions by means of lensfree video microscopy. Sci Rep 4:5942. http://dx.doi.org/10.1038/srep05942.
22. Cooke J, Butler C, Hopstaken R, Dryden MS, McNulty C, Hurding S, Moore M, Livermore DM. 2015. Narrative review of primary care pointof-care testing (POCT) and antibacterial use in respiratory tract infection (RTI). BMJ Open Respir Res 2:e000086. http://dx.doi.org/10.1136/bmjresp-2015-000086.
23. Moore CC, Jacob ST, Pinkerton R, Meya DB, Mayanja-Kizza H, Reynolds SJ, Scheld WM. 2008. Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda. Clin Infect Dis 46:215-222. http://dx.doi.org/10.1086/524665.
24. D’Acremont V, Kilowoko M, Kyungu E, Philipina S, Sangu W, Kahama-Maro J, Lengeler C, Cherpillod P, Kaiser L, Genton B. 2014. Beyond malaria—causes of fever in outpatient Tanzanian children. N Engl J Med 370:809-817. http://dx.doi.org/10.1056/NEJMoa1214482.
25. Dubourg G, Fenollar F. 2015. Epidemiologic studies need asymptomatic controls. Clin Microbiol Infect 21:e51-e52. http://dx.doi.org/10.1016/j.cmi.2015.04.020.
26. Yen CW, de Puig H, Tam JO, Gómez-Márquez J, Bosch I, Hamad-Schifferli K, Gehrke L. 2015. Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip 15:1638-1641. http://dx.doi.org/10.1039/C5LC00055F.
27. Mourembou G, Fenollar F, Socolovschi C, Lemamy GJ, Nzoughe H, Kouna LC, Toure-Ndouo F, Million M, Mbiguino AN, Lekana-Douki JB, Raoult D. 2015. Molecular detection of fastidious and common bacteria as well as Plasmodium spp. in febrile and afebrile children in Franceville, Gabon. Am J Trop Med Hyg 92:926-932. http://dx.doi.org/10.4269/ajtmh.14-0699.
28. Fujii Y, Kaneko S, Nzou SM, Mwau M, Njenga SM, Tanigawa C, Kimotho J, Mwangi AW, Kiche I, Matsumoto S, Niki M, Osada-Oka M, Ichinose Y, Inoue M, Itoh M, Tachibana H, Ishii K, Tsuboi T, Yoshida LM, Mondal D, Haque R, Hamano S, Changoma M, Hoshi T, Kamo K, Karama M, Miura M, Hirayama K. 2014. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl Trop Dis 8:e3040. http://dx.doi.org/10.1371/journal.pntd.0003040.
29. Mueller Y, D’Acremont V, Ambresin AE, Rossi I, Martin O, Burnand B, Genton B. 2014. Feasibility and clinical outcomes when using practice guidelines for evaluation of fever in returning travelers and migrants: a validation study. J Travel Med 21:169-182. http://dx.doi.org/10.1111/jtm.12099.
30. Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, Komatsu R, Korenromp E, Low-Beer D, Grabowsky M. 2009. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J 8:14. http://dx.doi.org/10.1186/1475-2875-8-14.
31. WHO. 2013. Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round 5 (2013). World Health Organization, Geneva, Switzerland.
32. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Vazquez S, Cartozian E, Pelegrino JL, Artsob H, Guzman MG, Olliaro P, Zwang J, Guillerm M, Kliks S, Halstead S, Peeling RW, Margolis HS. 2014. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS Negl Trop Dis 8:e3171. http://dx.doi.org/10.1371/journal.pntd.0003171.
33. Mediannikov O, Socolovschi C, Million M, Sokhna C, Bassene H, Diatta G, Fenollar F, Raoult D. 2014. Molecular identification of pathogenic bacteria in eschars from acute febrile patients, Senegal. Am J Trop Med Hyg 91:1015-1019. http://dx.doi.org/10.4269/ajtmh.13-0629.
34. Mediannikov O, Socolovschi C, Bassene H, Diatta G, Ratmanov P, Fenollar F, Sokhna C, Raoult D. 2014. Borrelia crocidurae infection in acutely febrile patients, Senegal. Emerg Infect Dis 20:1335-1338. http://dx.doi.org/10.3201/eid2008.130550.
35. Mediannikov O, Socolovschi C, Edouard S, Fenollar F, Mouffok N, Bassene H, Diatta G, Tall A, Niangaly H, Doumbo O, Lekana-Douki JB, Znazen A, Sarih M, Ratmanov P, Richet H, Ndiath MO, Sokhna C, Parola P, Raoult D. 2013. Common epidemiology of Rickettsia felis infection and malaria, Africa. Emerg Infect Dis 19:1775-1783. http://dx.doi.org/10.3201/eid1911.130361.
36. Strecker T, Palyi B, Ellerbrok H, Jonckheere S, de Clerck H, Bore JA, Gabriel M, Stoecker K, Eickmann M, van Herp M, Formenty P, Di Caro A, Becker S. 2015. Field evaluation of capillary blood samples as a collection specimen for the rapid diagnosis of Ebola virus infection during an outbreak emergency. Clin Infect Dis 61:669-675. http://dx.doi.org/10.1093/cid/civ397.
37. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, Sankoh AB, Kanu S, Jalloh A, Ton Q, Sarchet N, George P, Perkins MD, Wonderly B, Murray M, Pollock NR. 2015. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet 386:867-874. http://dx.doi.org/10.1016/S0140-6736(15)61042-X.
38. GBD 2013 Mortality and Causes of Death Collaborators. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117-171. http://dx.doi.org/10.1016/S0140-6736(14)61682-2.
39. Zhou H, Haber M, Ray S, Farley MM, Panozzo CA, Klugman KP. 2012. Invasive pneumococcal pneumonia and respiratory virus coinfections. Emerg Infect Dis 18:294-297. http://dx.doi.org/10.3201/eid1802.102025.
40. Shimada T, Noguchi Y, Jackson JL, Miyashita J, Hayashino Y, Kamiya T, Yamazaki S, Matsumura T, Fukuhara S. 2009. Systematic review and metaanalysis: urinary antigen tests for legionellosis. Chest 136:1576-1585. http://dx.doi.org/10.1378/chest.08-2602.
41. Sordé R, Falcó V, Lowak M, Domingo E, Ferrer A, Burgos J, Puig M, Cabral E, Len O, Pahissa A. 2011. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 171:166-172. http://dx.doi.org/10.1001/archinternmed.2010.347.
42. Cho CH, Woo MK, Kim JY, Cheong S, Lee CK, An SA, Lim CS, Kim WJ. 2013. Evaluation of five rapid diagnostic kits for influenza A/B virus. J Virol Methods 187:51-56. http://dx.doi.org/10.1016/j.jviromet.2012.09.003.
43. Salez N, Nougairede A, Ninove L, Zandotti C, de Lamballerie X, Charrel RN. 2014. Xpert Flu for point-of-care diagnosis of human influenza in industrialized countries. Expert Rev Mol Diagn 14:411-418. http://dx.doi.org/10.1586/14737159.2014.901152.
44. Salez N, Nougairede A, Ninove L, Zandotti C, de Lamballerie X, Charrel RN. 2015. Prospective and retrospective evaluation of the Cepheid Xpert Flu/RSV XC assay for rapid detection of influenza A, influenza B, and respiratory syncytial virus. Diagn Microbiol Infect Dis 81:256-258. http://dx.doi.org/10.1016/j.diagmicrobio.2015.01.008.
45. World Health Organization. 2014. Global tuberculosis report. World Health Organization, Geneva, Switzerland.
46. World Health Organization. 2014. TB diagnostics and laboratory strengthening. World Health Organization, Geneva, Switzerland.
47. Berg P, Lindhardt BØ. 2012. The role of procalcitonin in adult patients with community-acquired pneumonia—a systematic review. Dan Med J 59:A4357.
48. Pillet S, Lardeux M, Dina J, Grattard F, Verhoeven P, Le Goff J, Vabret A, Pozzetto B. 2013. Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS One 8:e72174. http://dx.doi.org/10.1371/journal.pone.0072174.
49. Leone M, Malavieille F, Papazian L, Meyssignac B, Cassir N, Textoris J, Antonini F, La Scola B, Martin C, Allaouchiche B, Hraiech S, AzuRea Network. 2013. Routine use of Staphylococcus aureus rapid diagnostic test in patients with suspected ventilator-associated pneumonia. Crit Care 17:R170. http://dx.doi.org/10.1186/cc12849.
50. Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM, Cunningham SA, Pritt BS, Patel R, Binnicker MJ. 2014. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol 52:3667-3673. http://dx.doi.org/10.1128/JCM.01637-14.
51. Lagier JC, Delord M, Million M, Parola P, Stein A, Brouqui P, Raoult D. 2015. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report. Eur J Clin Microbiol Infect Dis 34:1597-1601. http://dx.doi.org/10.1007/s10096-015-2394-x.
52. Orellana-Miguel MA, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sánchez F. 2013. Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm Infecc Microbiol Clin 31:97-99. http://dx.doi.org/10.1016/j.eimc.2012.01.003.
53. Goldenberg SD, Bisnauthsing KN, Patel A, Postulka A, Wyncoll D, Schiff R, French GL. 2014. Point-of-care testing for Clostridium difficile infection: a real-world feasibility study of a rapid molecular test in two hospital settings. Infect Dis Ther 3:295-306. http://dx.doi.org/10.1007/s40121-014-0038-6.
54. Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H, Nebbad B, Camiade S, Meckenstock R, Lalande V, Marchandin H, Barbut F. 2014. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect 3:12-17. http://dx.doi.org/10.1016/j.nmni.2014.10.003.
55. Dediste A, Vandenberg O, Vlaes L, Ebraert A, Douat N, Bahwere P, Butzler JP. 2003. Evaluation of the ProSpecT microplate assay for detection of Campylobacter: a routine laboratory perspective. Clin Microbiol Infect 9:1085-1090. http://dx.doi.org/10.1046/j.1469-0691.2003.00705.x.
56. Taneja N, Nato F, Dartevelle S, Sire JM, Garin B, Thi Phuong LN, Diep TT, Shako JC, Bimet F, Filliol I, Muyembe JJ, Ungeheuer MN, Ottone C, Sansonetti P, Germani Y. 2011. Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples. PLoS One 6:e24830. http://dx.doi.org/10.1371/journal.pone.0024830.
57. Duran C, Nato F, Dartevelle S, Thi Phuong LN, Taneja N, Ungeheuer MN, Soza G, Anderson L, Benadof D, Zamorano A, Diep TT, Nguyen TQ, Nguyen VH, Ottone C, Bégaud E, Pahil S, Prado V, Sansonetti P, Germani Y. 2013. Rapid diagnosis of diarrhea caused by Shigella sonnei using dipsticks; comparison of rectal swabs, direct stool and stool culture. PLoS One 8:e80267. http://dx.doi.org/10.1371/journal.pone.0080267.
58. Smith L, Angarone MP. 2015. Sexually transmitted infections. Urol Clin North Am 42:507-518. http://dx.doi.org/10.1016/j.ucl.2015.06.004.
59. Huppert JS, Taylor RG, St Cyr S, Hesse EA, Reed JL. 2013. Point-ofcare testing improves accuracy of STI care in an emergency department. Sex Transm Infect 89:489-494. http://dx.doi.org/10.1136/sextrans-2012-050994.
60. Tucker JD, Bien CH, Peeling RW. 2013. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 26:73-79. http://dx.doi.org/10.1097/QCO.0b013e32835c21b0.
61. Jafari Y, Johri M, Joseph L, Vadnais C, Pant Pai N. 2014. Poor reporting of outcomes beyond accuracy in point-of-care tests for syphi-lis: a call for a framework. AIDS Res Treat 2014:465-932. http://dx.doi.org/10.1155/2014/465932.
62. Turner KM, Round J, Horner P, Macleod J, Goldenberg S, Deol A, Adams EJ. 2014. An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary medicine clinics in England. Sex Transm Infect 90:104-111. http://dx.doi.org/10.1136/sextrans-2013-051147.
63. Bretelle F, Rozenberg P, Pascal A, Favre R, Bohec C, Loundou A, Senat MV, Aissi G, Lesavre N, Brunet J, Heckenroth H, Luton D, Raoult D, Fenollar F, Groupe de Recherche en Obstetrique Gynecologie. 2015. High Atopobium vaginae and Gardnerella vaginalis vaginal loads are associated with preterm birth. Clin Infect Dis 60:860-867. http://dx.doi.org/10.1093/cid/ciu966.
64. Blankenstein T, Lytton SD, Leidl B, Atweh E, Friese K, Mylonas I. 2015. Point-of-care (POC) diagnosis of bacterial vaginosis (BV) using VGTest ion mobility spectrometry (IMS) in a routine ambulatory care gynecology clinic. Arch Gynecol Obstet 292:355-362. http://dx.doi.org/10.1007/s00404-014-3613-x.
65. Allier CP, Hiernard G, Poher V, Dinten JM. 2010. Bacteria detection with thin wetting film lensless imaging. Biomed Opt Express 1:762-770. http://dx.doi.org/10.1364/BOE.1.000762.
66. Cohen-Bacrie S, Ninove L, Nougairède A, Charrel R, Richet H, Minodier P, Badiaga S, Noël G, La Scola B, de Lamballerie X, Drancourt M, Raoult D. 2011. Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One 6:e22403. http://dx.doi.org/10.1371/journal.pone.0022403.
67. Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin Z, Taseera K, Schutz C, Kwizera R, Butler EK, Meintjes G, Muzoora C, Bischof JC, Meya DB. 2014. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis 20:45-53. http://dx.doi.org/10.3201/eid2001.130906.
68. Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. 2011. Evaluation of a novel pointof-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 53: 1019-1023. http://dx.doi.org/10.1093/cid/cir613.
69. Kwizera R, Nguna J, Kiragga A, Nakavuma J, Rajasingham R, Boulware DR, Meya DB. 2014. Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 _100. PLoS One 9:e103156. http://dx.doi.org/10.1371/journal.pone.0103156.
70. Chapin KC, Blake P, Wilson CD. 2002. Performance characteristics and utilization of rapid antigen test, DNA probe, and culture for detection of group A streptococci in an acute care clinic. J Clin Microbiol 40:4207-4210. http://dx.doi.org/10.1128/JCM.40.11.4207-4210.2002.
71. Calviño O, Llor C, Gómez F, González E, Sarvisé C, Hernández S. 2014. Association between C-reactive protein rapid test and group A streptococcus infection in acute pharyngitis. J Am Board Fam Med 27: 424-426. http://dx.doi.org/10.3122/jabfm.2014.03.130315.
72. Weber NC, Klepser ME, Akers JM, Klepser DG, Adams AJ. 2016. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. Expert Rev Mol Diagn 16:253-264. http://dx.doi.org/10.1586/14737159.2015.1116388.
73. Swain GR, McDonald RA, Pfister JR, Gradus MS, Sedmak GV, Singh A. 2004. Decision analysis: point-of-care chlamydia testing vs. laboratory-based methods. Clin Med Res 2:29-35. http://dx.doi.org/10.3121/cmr.2.1.29.
74. Nicol MP, Whitelaw A, Wendy S. 2013. Using Xpert MTB/RIF. Curr Respir Med Rev 9:187-192. http://dx.doi.org/10.2174/1573398X113099990015.
75. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377:1495-1505. http://dx.doi.org/10.1016/S0140-6736(11)60438-8.
76. Patel JC, Lucchi NW, Srivastava P, Lin JT, Sug-Aram R, Aruncharus S, Bharti PK, Shukla MM, Congpuong K, Satimai W, Singh N, Udhayakumar V, Meshnick SR. 2014. Field evaluation of a real-time fluorescence loop-mediated isothermal amplification assay, RealAmp, for the diagnosis of malaria in Thailand and India. J Infect Dis 210:1180-1187. http://dx.doi.org/10.1093/infdis/jiu252.
77. Goyal A, Kaur H, Sehgal A, Sehgal R. 2015. RealAmp loop-mediated isothermal amplification as a point-of-care test for diagnosis of malaria: neither too close nor too far. J Infect Dis 211:1686. http://dx.doi.org/10.1093/infdis/jiu810.
78. Babonneau J, Bernard C, Marion E, Chauty A, Kempf M, Robert R, Marsollier L, Franco-Beninese Buruli Research Group. 2015. Development of a dry-reagent-based qPCR to facilitate the diagnosis of Mycobacterium ulcerans infection in endemic countries. PLoS Negl Trop Dis 9:e0003606. http://dx.doi.org/10.1371/journal.pntd.0003606.
79. Moore C. 2013. Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line? J Hosp Infect 85:1-7. http://dx.doi.org/10.1016/j.jhin.2013.06.005.
80. Fox JW, Cohen DM, Marcon MJ, Cotton WH, Bonsu BK. 2006. Performance of rapid streptococcal antigen testing varies by personnel. J Clin Microbiol 44:3918-3922. http://dx.doi.org/10.1128/JCM.01399-06.
81. Menard JP, Fenollar F, Raoult D, Boubli L, Bretelle F. 2012. Selfcollected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis 31:513-518. http://dx.doi.org/10.1007/s10096-011-1341-8.
82. Tamalet C, Le Retraite L, Leandri FX, Heid P, Sancho Garnier H, Piana L. 2013. Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening. Clin Microbiol Infect 19:E44-E50. http://dx.doi.org/10.1111/1469-0691.12063.
83. Paudyal P, Llewellyn C, Lau J, Mahmud M, Smith H. 2015. Obtaining self-samples to diagnose curable sexually transmitted infections: a systematic review of patients’ experiences. PLoS One 10:e0124310. http://dx.doi.org/10.1371/journal.pone.0124310.
84. Anonymous. 2009. Clinical laboratory improvement amendments (CLIA). US Department of Health and Human Services, Washington, DC.
85. Smit PW, Mabey D, van der Vlis T, Korporaal H, Mngara J, Changalucha J, Todd J, Peeling RW. 2013. The implementation of an external quality assurance method for point-of-care tests for HIV and syphilis in Tanzania. BMC Infect Dis 13:530. http://dx.doi.org/10.1186/1471-2334-13-530.
86. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. 2012. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in lowand middle-income countries. PLoS Med 9:e1001306. http://dx.doi.org/10.1371/journal.pmed.1001306.
87. Abat C, Chaudet H, Colson P, Rolain JM, Raoult D. 2015. Real-time microbiology laboratory surveillance system to detect abnormal events and emerging infections, Marseille, France. Emerg Infect Dis 21:1302-1310. http://dx.doi.org/10.3201/eid2108.141419.
88. Angelakis E, Mediannikov O, Socolovschi C, Mouffok N, Bassene H, Tall A, Niangaly H, Doumbo O, Znazen A, Sarih M, Sokhna C, Raoult D. 2014. Coxiella burnetii-positive PCR in febrile patients in rural and urban Africa. Int J Infect Dis 28:107-110. http://dx.doi.org/10.1016/j.ijid.2014.05.029.
89. Fine AM, Nizet V, Mandl KD. 2011. Improved diagnostic accuracy of group A streptococcal pharyngitis with use of real-time biosurveillance. Ann Intern Med 155:345-352. http://dx.doi.org/10.7326/0003-4819-155 -6-201109200-00002.
90. Holm A, Cordoba G, Sørensen TM, Jessen LR, Siersma V, Bjerrum L. 2015. Point of care susceptibility testing in primary care—does it lead to a more appropriate prescription of antibiotics in patients with uncomplicated urinary tract infections? Protocol for a randomized controlled trial. BMC Fam Pract 16:106. http://dx.doi.org/10.1186/s12875-015-0322-x.
91. Ninove L, Nougairede A, Gazin C, Zandotti C, Drancourt M, de Lamballerie X, Charrel RN. 2011. Comparative detection of enterovirus RNA in cerebrospinal fluid: GeneXpert system vs. real-time RT-PCR assay. Clin Microbiol Infect 17:1890-1894. http://dx.doi.org/10.1111/j.1469-0691.2011.03487.x.
92. WHO. 2015. Cost-effectiveness thresholds. WHO, Geneva, Switzerland.
93. Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F. 2011. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a costeffectiveness analysis. PLoS Med 8:e1001120. http://dx.doi.org/10.1371/journal.pmed.1001120.
94. Menzies NA, Cohen T, Lin H-H, Murray M, Salomon JA. 2012. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 9:e1001347. http://dx.doi.org/10.1371/journal.pmed.1001347.
95. Langley I, Lin HH, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. 2014. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modeling approach. Lancet Glob Health 2:e581-e591. http://dx.doi.org/10.1016/S2214-109X(14)70291-8.
96. Winetsky DE, Negoescu DM, DeMarchis EH, Almukhamedova O, Dooronbekova A, Pulatov D, Vezhnina N, Owens DK, Goldhaber-Fiebert JD. 2012. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med 9:e1001348. http://dx.doi.org/10.1371/journal.pmed.1001348.
97. Choi HW, Miele K, Dowdy D, Shah M. 2013. Cost-effectiveness of Xpert MTB/RIF for diagnosing pulmonary tuberculosis in the United States. Int J Tuberc Lung Dis 17:1328-1335. http://dx.doi.org/10.5588/ijtld.13.0095.
98. Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. 2014. Modeling of novel diagnostic strategies for active tuberculosis—a systematic review: current practices and recommendations. PLoS One 9:e110558. http://dx.doi.org/10.1371/journal.pone.0110558.
99. Lemma H, Sebastian MS, Löfgren C, Barnabas G. 2011. Costeffectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax codominate. Cost Eff Resour Alloc 9:2. http://dx.doi.org/10.1186/1478-7547-9-2.
100. Batwala V, Magnussen P, Hansen KS, Nuwaha F. 2011. Costeffectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J 10:372. http://dx.doi.org/10.1186/1475-2875-10-372.
101. Chanda P, Castillo-Riquelme M, Masiye F. 2009. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc 7:5. http://dx.doi.org/10.1186/1478-7547-7-5.
102. Ansah EK, Epokor M, Whitty CJM, Yeung S, Hansen KS. 2013. Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. Am J Trop Med Hyg 89:724-736. http://dx.doi.org/10.4269/ajtmh.13-0033.
103. De Oliveira MRF, de Castro Gomes A, Toscano CM. 2010. Cost effectiveness of OptiMal rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil. Malar J 9:277. http://dx.doi.org/10.1186 /1475-2875-9-277.
104. Loubiere S, Moatti JP. 2010. Economic evaluation of point-of-care diagnostic technologies for infectious diseases. Clin Microbiol Infect 16: 1070-1076. http://dx.doi.org/10.1111/j.1469-0691.2010.03280.x.
105. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills A. 2008. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86:101-110. http://dx.doi.org/10.2471/BLT.07.042259.
106. Uzochukwu BS, Obikeze EN, Onwujekwe OE, Onoka CA, Griffiths UK. 2009. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Malar J 8:265. http://dx.doi.org/10.1186/1475-2875-8-265.
107. Msellem MI, Mårtensson A, Rotllant G, Bhattarai A, Strömberg J, Kahigwa E, Garcia M, Petzold M, Olumese P, Ali A, Björkman A. 2009. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar—a crossover validation study. PLoS Med 6:e1000070. http://dx.doi.org/10.1371/journal.pmed.1000070.
108. Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ. 2008. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am J Trop Med Hyg 78:884-891.
109. Rydzak CE, Goldie SJ. 2008. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis 35: 775-784. http://dx.doi.org/10.1097/OLQ.0b013e318176196d.
110. Owusu-Edusei K, Gift TL, Ballard RC. 2011. Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sex Transm Dis 38: 997-1003. http://dx.doi.org/10.1097/OLQ.0b013e3182260987.
111. Kuznik A, Lamorde M, Nyabigambo A, Manabe YC. 2013. Antenatal syphilis screening using point-of-care testing in sub-Saharan African countries: a cost-effectiveness analysis. PLoS Med 10:e1001545. http://dx.doi.org/10.1371/journal.pmed.1001545.
112. Huang W, Gaydos CA, Barnes MR, Jett-Goheen M, Blake DR. 2013. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Infect 89:108-114. http://dx.doi.org/10.1136/sextrans-2011-050355.
113. Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. 2010. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess 14:1-97. http://dx.doi.org/10.3310/hta14290.
114. Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka M, Ndeki L, Whitehouse A, Balira R, Todd J, Ngeleja D, Ross D, Buvé A, Hayes R, Mabey D. 2002. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186:940-947. http://dx.doi.org/10.1086/342952.
115. Baden T, Chagas AM, Gage GJ, Marzullo TC, Prieto-Godino LL, Euler T. 2015. Open Labware: 3-D printing your own lab equipment. PLoS Biol 13:e1002086. http://dx.doi.org/10.1371/journal.pbio.1002086.
116. Chin CD, Laksanasopin T, Cheung YK, Steinmiller D, Linder V, Parsa H, Wang J, Moore H, Rouse R, Umviligihozo G, Karita E, Mwambarangwe L, Braunstein SL, van de Wijgert J, Sahabo R, Justman JE, El-Sadr W, Sia SK. 2011. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med 17:1015-1019. http://dx.doi.org/10.1038/nm.2408.
117. Laksanasopin T, Guo TW, Nayak S, Sridhara AA, Xie S, Olowookere OO, Cadinu P, Meng F, Chee NH, Kim J, Chin CD, Munyazesa E, Mugwaneza P, Rai AJ, Mugisha V, Castro AR, Steinmiller D, Linder V, Justman JE, Nsanzimana S, Sia SK. 2015. A smartphone dongle for diagnosis of infectious diseases at the point of care. Sci Transl Med 7:273re1. http://dx.doi.org/10.1126/scitranslmed.aaa0056.
118. Huang JM, Henihan G, Macdonald D, Michalowski A, Templeton K, Gibb AP, Schulze H, Bachmann TT. 2015. Rapid electrochemical detection of New Delhi metallo-beta-lactamase genes to enable point-ofcare testing of carbapenem-resistant Enterobacteriaceae. Anal Chem 87: 7738-7745. http://dx.doi.org/10.1021/acs.analchem.5b01270.